PFM Health Sciences’s CarMax KMX Stock Holding History

PFM Health Sciences’s Portfolio KMX Stock Details KMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-329,301	Closed	-$21.2M	–	111
2016 Q4	$21.2M	Buy	+329,301	New	+$18.5M	0.6%	55

Other funds holding KMX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCG

Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

ACM

AKRE Capital Management Middleburg, Virginia $6.13B AUM 15.27% 1-Year Est. Return

PFM Health Sciences's KMX Position: Q1 2017 in Review

PFM Health Sciences sold out of CarMax (KMX) in Q1 2017, closing a stake of 329,301 shares — an estimated $21.2M sold.

PFM Health Sciences first reported a position in KMX in Q4 2016 and held it in 1 quarter. The position peaked at $21.2M in Q4 2016. 468 funds tracked by Wall St. Rank hold KMX as of Q1 2017.

PFM Health Sciences reported no remaining CarMax position as of Q1 2017 after selling out during the quarter.
PFM Health Sciences sold 329,301 CarMax shares in Q1 2017, an estimated $21.2M.
PFM Health Sciences first reported a position in CarMax in Q4 2016 and held it in 1 quarter.
PFM Health Sciences's CarMax position peaked at $21.2M in Q4 2016.
468 funds tracked by Wall St. Rank held CarMax as of Q1 2017.

Based on PFM Health Sciences's 13F filing for Q1 2017, filed 15 May 2017.